Cover Image
市場調查報告書

美國的乳癌診斷設備市場機會:2010∼2020年

United States Breast Cancer Diagnostic Devices Market Opportunities, 2010 - 2020

出版商 Pharmaion 商品編碼 351613
出版日期 內容資訊 英文 108 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
美國的乳癌診斷設備市場機會:2010∼2020年 United States Breast Cancer Diagnostic Devices Market Opportunities, 2010 - 2020
出版日期: 2016年02月04日 內容資訊: 英文 108 Pages
簡介

根據BreatCancer.org的統計,預計美國女性8人有1人在一生中會患乳癌。2015年,美國確診了231,840件新的濕潤性乳癌和60,290件非濕潤性乳癌。由於罹患率增加與對乳癌相關意識提升,一般認為檢驗和診斷的需求踏實擴大。

本報告提供美國的乳癌診斷設備市場相關調查,市場規模與佔有率,至2020年的預測,各類型,各地區趨勢,法律制度,新興機會及競爭趨勢,及參與企業簡介等彙整資料。

第1章 乳癌診斷設備概要

第2章 美國的乳癌流行病學

第3章 調查方法

第4章 分析師的見解

第5章 全球乳癌診斷設備市場概要

第6章 美國的乳癌診斷設備市場概要

第7章 美國的乳癌診斷設備市場預測

  • 市場規模與預測
  • 市場佔有率與預測
    • 各類型
    • 各終端用戶
    • 各地區
    • 各企業

第8章 美國的檢驗診斷用影像設備市場預測

  • 市場規模與預測
  • 市場佔有率與預測
  • 乳房X光攝影

第9章 美國的實驗室診斷設備市場預測

  • 市場規模與預測
  • 市場佔有率與預測

第10章 市場趨勢

  • 促進要素
  • 課題

第11章 市場趨勢與發展

  • 顯影劑的乳房X光攝影
  • 新乳癌診斷生物標記
  • 吸引式乳房組織切片檢查
  • 乳房X光攝影用CAD
  • 核子乳房攝影

第12章 美國的經濟簡介

第13章 政策與法律制度

第14章 償付方案

第15章 競爭環境

  • 競爭基準
  • 企業簡介
    • Hologic Inc.
    • Siemens Healthcare Diagnostics, Inc
    • Devicor Medical Products, Inc. (Mammotome)
    • GE Healthcare
    • Philips Healthcare
    • Carestream Health
    • Fujifilm Medical Systems, U.S.A., Inc.
    • IMS S.r.l.
    • Planmed OY
    • CareFusion Corporation

第16章 策略性建議

圖表

目錄
Product Code: P014

As per the statistics furnished by the BreastCancer.org, one in every eight women in the US is anticipated to develop breast cancer over the course of her lifetime. In 2015, an estimated 231,840 new cases of invasive breast cancer and 60,290 new cases of non-invasive breast cancer have been diagnosed in the US. With rising prevalence rate and growing awareness regarding breast cancer, demand for screening and diagnosis is increasing at a robust pace in the United States.

“United States Breast Cancer Diagnostic Devices Market Opportunities, 2010 - 2020” report studies the market size and share of various segments and sub-segments of the breast cancer diagnostic devices market in the United States during the period 2010 - 2020. In the study, the market has been categorized into three broader segments that include Screening and Diagnostic Imaging Devices, Lab Diagnostic Devices and Others.

The market dynamics section of the report elaborates about the factors driving the market as well as the challenges inhibiting growth. The research study also includes insights of the key market trends, a detailed analysis of the changing competitive landscape, and revenue forecasts for each segment and sub-segment.

All this information is provided to assist the established market players and new entrants in taking their strategic decisions, thereby aiding them in strengthening their market position in a highly competitive breast cancer diagnostic devices market in the United States.

“United States Breast Cancer Diagnostic Devices Market Opportunities, 2010 - 2020” report elaborates the following aspects of breast cancer diagnostic devices market in the United States:

  • United States Breast Cancer Diagnostics Market Size, Share & Forecast
  • Segmental Analysis - By Test Type, By Region, By End User, By Company
  • Policy & Regulatory Landscape
  • Changing Market Trends & Emerging Opportunities
  • Competitive Landscape & Strategic Recommendations

Why You Should Buy This Report?

  • To identify the on-going trends and anticipated growth in the next five years
  • To gain competitive knowledge of leading market players
  • To avail 10% customization in the report without any extra charges and get the research data or trends added in the report as per the buyer's specific needs

Key Questions This Study Will Answer

  • What would be the segmental and regional growth trends in the United States breast cancer diagnostic devices market in the coming years?
  • What are the most important growth drivers and opportunities in the market?
  • Which breast cancer diagnostic procedures is preferred the most?
  • What strategies should market competitors employ to gain share in mature segments of the United States breast cancer diagnostic devices market?
  • What are the competitor profiles in this market and how do they compete for market share?

Report Methodology

The information contained in this report is based upon both primary and secondary sources. Primary research included interviews with breast cancer screening and diagnostic devices manufacturers and industry experts. Secondary research included an exhaustive search of relevant publications like company annual reports, financial reports and other proprietary databases.

Table of Contents

1. Breast Cancer Diagnostic Devices Overview

2. United States Breast Cancer Epidemiology

3. Research Methodology

4. Analyst View

5. Global Breast Cancer Diagnostic Devices Market Overview

6. United States Breast Cancer Diagnostic Devices Market Overview

7. United States Breast Cancer Diagnostic Devices Market Outlook

  • 7.1. Market Size and Forecast
    • 7.1.1. By Value
  • 7.2. Market Share and Forecast
    • 7.2.1. By Test Type
    • 7.2.2. By End-user
    • 7.2.3. By Region
    • 7.2.4. By Company

8. United States Screening and Diagnostic Imaging Devices Market Outlook

  • 8.1. Market Size and Forecast
    • 8.1.1. By Value
  • 8.2. Market Share and Forecast
    • 8.2.1. By Test Type
  • 8.3. United States Mammography Market Outlook
    • 8.3.1. Market Size and Forecast
      • 8.3.1.1. By Value
    • 8.3.2. Market Share and Forecast
      • 8.3.2.1. By Type (Analog Mammography, 3D Mammography, Full Field Digital Mammography)

9. United States Lab Diagnostic Devices Market Outlook

  • 9.1. Market Size and Forecast
    • 9.1.1. By Value
  • 9.2. Market Share and Forecast
    • 9.2.1. By Test Type

10. Market Dynamics

  • 10.1. Drivers
  • 10.2. Challenges

11. Market Trends & Developments

  • 11.1. Contrast-enhanced Mammography
  • 11.2. Novel Breast Cancer Diagnostics Biomarkers
  • 11.3. Vacuum-Assisted Biopsy
  • 11.4. CAD for Mammography
  • 11.5. Scintimammography

12. United States Economic Profile

13. Regulatory Landscape

14. Reimbursement Scenario

15. Competitive Landscape

  • 15.1. Competitive Benchmarking
  • 15.2. Company Profiles
    • 15.2.1. Hologic Inc.
    • 15.2.2. Siemens Healthcare Diagnostics, Inc
    • 15.2.3. Devicor Medical Products, Inc. (Mammotome)
    • 15.2.4. GE Healthcare
    • 15.2.5. Philips Healthcare
    • 15.2.6. Carestream Health
    • 15.2.7. Fujifilm Medical Systems, U.S.A., Inc.
    • 15.2.8. IMS S.r.l.
    • 15.2.9. Planmed OY
    • 15.2.10. CareFusion Corporation

16. Strategic Recommendations

List of Figures

  • Figure 1: United States Breast Cancer Diagnostic Devices Market Size, By Value, 2010-2020F (USD Billion)
  • Figure 2: United States Breast Cancer Diagnostic Devices Market Share, By Test Type, By Value, 2010-2020F
  • Figure 3: United States Breast Cancer Diagnostic Devices Market Share, By End User, By Value, 2010-2020F
  • Figure 4: United States Breast Cancer Diagnostic Devices Market Size, By Region, By Value, 2010-2014 (USD Million)
  • Figure 5: United States Breast Cancer Diagnostic Devices Market Size, By Region, By Value, 2015-2020 (USD Million)
  • Figure 6: United States Breast Cancer Diagnostic Devices Market Share, By Region, By Value, 2010-2020F
  • Figure 7: United States Breast Cancer Diagnostic Devices Market Share, By Company, By Value, 2010-2020F
  • Figure 8: United States Screening and Diagnostic Imaging Devices Market Size, By Value, 2010-2020F (USD Billion)
  • Figure 9: United States Breast Cancer Screening and Diagnostic Devices Market Share, By Test Type, By Value, 2010-2020F
  • Figure 10: United States Mammography Market Size, By Value, 2010-2020F (USD Billion)
  • Figure 11: United States Mammography Market Share, By Type, By Value, 2010-2020F
  • Figure 12: Difference between Analog, 2D and 3D Mammography (Same Patient), By Image Quality
  • Figure 13: United States Lab Diagnostic Devices Market Size, By Value, 2010-2020F (USD Billion)
  • Figure 14: United States Lab Diagnostic Devices Market Share, By Test Type, By Value, 2010-2020F
  • Figure 15: Comparison of Standard Mammograph Image and Contrast-enhanced Spectral Mammogram Image

List of Table

  • Table 1: Estimated US Breast Cancer Statistics, 2015
  • Table 2: United States Number of People Aged 65 & Above, 1900 - 2060F
  • Table 3: Percent of U.S. Women Who Develop Breast Cancer over 10-, 20-, and 30-Year Intervals According to Their Current Age, 2010-2012
  • Table 4: United States Women Using Mammography (%) within Past Two Years, By age, 1987 - 2013
  • Table 5: Characteristics Helping Radiologist Differentiate Between Benign and Malignant Tumor
  • Table 6: Types of Breast Biopsy
  • Table 7: Lifetime Attributable Risk (LAR) of Breast Cancer Incidence and Mortality per 100,000 Women Undergoing Annual Screening Mammography, By Age (Average Glandular Dose: 3.7 mGy (DM) to 4.7 mGy (SFM) per exam)
  • Table 8: Major Diagnostic microRNA Signatures for the Early Diagnosis of Breast Cancer
  • Table 9: Sensitivity of Different Views Based on Lesion Type and Mammography
  • Table 10: Reimbursement Scenario of Screening and Diagnostic Mammograms and Breast Ultrasound, 2013 & 2014 (USD)
  • Table 11: New CPT Codes for Percutaneous Breast Procedures, 2014
  • Table 12: Major Companies Offering Products included in Others Segment
Back to Top